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Inflammation has been known to human-
kind for at least a few thousand years, in 
part because it accompanied two major 
scourges of the past, wounds and infec-
tions, and in part because it is rather con-
spicuous. Although references to inflam-
mation can be found in ancient medical 
texts, apparently the first to define its 
clinical symptoms was the Roman doc-
tor Cornelius Celsus in the 1st century 
AD. These symptoms came to be known 
as the four cardinal signs of inflamma-
tion: rubor et tumor cum calore et dolore 
(redness and swelling with heat and 
pain). Celsus mentions these signs in his 
treatise De medicina, while describing 
procedures for treating chest pain, and 
in so doing became an oft-quoted medi-
cal celebrity (Majno, 1975).
The physiological basis of the four 
cardinal signs of inflammation was 
revealed much later by Augustus Waller 
(1846) and Julius Cohnheim (1867), who 
discovered leukocyte emigration from 
the blood vessels and other vascu-
lar changes characteristic of an acute 
inflammatory response. Analyzing living 
tissues under the microscope, Cohn-
heim observed vasodilation, leakage of 
plasma, and migration of leukocytes out 
of blood vessels and into the surround-
ing tissue (Majno and Joris, 2004).
The fifth cardinal sign, functio laesa 
(disturbance of function), was added 
by Rudolph Virchow in 1858 in his book 
Cellularpathologie (Majno, 1975). Nota-
bly, although the four cardinal signs of 
Celsus only apply to acute inflammation 
accompanying wounds and infections, 
functio laesa is the only universal sign 
that accompanies all inflammatory pro-
cesses. Virchow’s main contribution to 
inflammation research was to establish 
the cellular basis of pathology, a dra-
matic departure from the traditional view 
of disease as an imbalance of the four 
humors, which had dominated medicine 
since the time of Hippocrates.
Another major milestone was the dis-
covery of phagocytosis by Elie Metch-
nikoff and his theory of cellular immu-
nity developed in 1892. Metchnikoff 
emphasized the beneficial aspects of 
inflammation and pointed out the key 
role of macrophages and microphages 
(neutrophils) both in host defense and in 
the maintenance of tissue homeostasis 
(Tauber, 2003). We now appreciate the 
importance of these concepts, as we 
learn more about the biological func-
tions of inflammation and the roles of 
macrophages in diseases of impaired 
homeostasis, such as obesity and ath-
erosclerosis. Meanwhile, Paul Ehrlich 
was busy developing the humoral theory 
of immunity following the discovery of 
serum therapy against diphtheria and 
tetanus toxins by Emil von Behring and 
Shibasaburo Kitasato in 1890. The role 
of serum components in immunity was 
further supported by the discovery of 
complement by Jules Bordet in 1896. 
Finally, the establishment of the germ 
theory of disease in the late 19th century 
by Robert Koch and Louis Pasteur was 
crucial for appreciating microbial agents 
as major inducers of the acute inflamma-
tory response.
Subsequent advances included the 
identification of different classes of 
inflammatory mediators, the pathways 
that control their production, and their 
mechanisms of action. We now know 
that inflammation comes in many dif-
ferent forms and modalities, which are 
governed by different mechanisms of 
induction, regulation, and resolution. In 
the past few decades, the spectrum of 
prevailing inflammatory conditions has 
shifted from acute inflammatory reac-
tions in response to wounds and infec-
tions to chronic inflammatory states 
that accompany, for example, type 2 
diabetes, atherosclerosis, asthma, neu-
rodegenerative diseases, and cancer. It 
is as if surviving wounds and infections 
early in life almost guarantees encoun-
tering chronic inflammatory diseases at 
an advanced age. It is therefore hard to 
overestimate the role of inflammatory 
processes in human health and disease. 
And as we cannot completely escape 
from inflammation, we should at least try 
to understand it well enough to be able 
to avoid its more unpleasant aspects.
A Spectrum of Inflammatory 
Responses
A typical inflammatory response con-
sists of four components: inflammatory 
inducers, the sensors that detect them, 
the inflammatory mediators induced by 
the sensors, and the target tissues that 
are affected by the inflammatory media-
tors (Figure 1). Each component comes 
in multiple forms and their combina-
tions function in distinct inflammatory 
pathways. The type of pathway induced 
under given conditions depends on 
the nature of the inflammatory trigger. 
Thus, bacterial pathogens are detected 
by receptors of the innate immune sys-
tem, such as Toll-like receptors (TLRs), 
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which are expressed on tissue-resident 
macrophages and induce the produc-
tion of inflammatory cytokines (e.g., TNF, 
IL-1, IL-6) and chemokines (e.g., CCL2 
and CXCL8), as well as prostaglandins. 
These inflammatory mediators then 
act on target tissues, including local 
blood vessels, to induce vasodilation, 
extravasation of neutrophils, and leak-
age of plasma into the infected tissue. 
Neutrophils recruited from the circula-
tion, tissue-resident macrophages, and 
mast cells seek and destroy invading 
pathogens. This process is aided by 
plasma components, including antibod-
ies and complement. In addition, IL-1, 
TNF, and IL-6 can have systemic effects 
when secreted in sufficient amounts. 
They induce liver cells (hepatocytes) to 
produce acute phase proteins such as 
C-reactive protein and coagulation fac-
tors, and they activate brain endothelium 
to produce prostaglandins, including the 
major proinflammatory prostaglandin, 
PGE2. Locally produced PGE2, in turn, 
induces specific populations of neurons 
in the central nervous system to pro-
mote so-called sickness behavior: fever, 
anorexia, fatigue, sleepiness, and social 
withdrawal (Pecchi et al., 2009).
Depending on the type of infection 
(bacterial, viral, or parasitic), the sensors, 
mediators, and target tissues vary such 
that the appropriate type of inflammatory 
response is induced. For example, viral 
infections induce the production of type-
I interferons (IFN-α, IFN-β) by infected 
cells and the activation of cytotoxic lym-
phocytes, whereas infections with para-
sitic worms lead to the production of his-
tamine, IL-4, IL-5, and IL-13 by mast cells 
and basophils. The latter response can 
also be triggered by allergens, resulting 
in allergic inflammation that affects pri-
marily the mucosal epithelium, smooth 
muscles, and vasculature.
In the case of sterile tissue injury in the 
absence of infection, acute inflammation 
promotes tissue repair and helps to pre-
vent colonization of the damaged tissues 
by opportunistic pathogens. The molec-
ular identities of the triggers and sensors 
involved in the inflammatory response 
to tissue injury are incompletely under-
stood, although molecules released 
from dying cells, breakdown products 
of the extracellular matrix, and products 
of the proteolytic cascades activated 
by vascular damage are thought to be 
involved. Tissue damage is detected 
by both tissue-resident macrophages, 
which induce inflammatory and repara-
tive responses, and by pain receptors 
(nociceptors) that enable pain sensa-
tion in the affected area. Interestingly, 
both types of tissue damage sensors 
can be activated by some of the same 
signals that are produced upon injury, 
for example, extracellular ATP released 
from dying cells and bradykinin gener-
ated by a proteolytic cascade induced 
by vascular damage (Basbaum et al., 
2009). Inflammation and nociception 
are functionally linked at multiple levels: 
exudate formation, tissue swelling, and 
inflammatory mediators are responsible 
for “inflammatory pain,” and nocicep-
tion complements inflammatory sen-
sors in monitoring tissue homeostasis. 
In addition, prostaglandins can lower the 
threshold of pain sensation by increasing 
the sensitivity of nociceptors. Notably, 
sensing of the inflammatory milieu by the 
vagus nerve triggers an “inflammatory 
reflex,” which is involved in the negative 
control of inflammation (Tracey, 2002).
The acute inflammatory response is nor-
mally terminated once the triggering insult 
is eliminated, the infection is cleared, and 
damaged tissue is repaired. Termination 
of the inflammatory response and transi-
tion to the homeostatic state is an active 
and highly regulated process known as 
the resolution of inflammation. Several key 
regulatory mechanisms of resolution have 
been identified including the switch from 
proinflammatory prostaglandins to anti-
inflammatory, resolution-inducing lipoxins. 
This switch, in turn, orchestrates a transi-
tion from neutrophil to monocyte recruit-
ment that results in clearance of the dead 
cells and other debris and initiation of tis-
sue repair at the affected site (Serhan and 
Savill, 2005). If the inflammatory trigger is 
not eliminated by the acute inflammatory 
response or persists for any other reason, 
the resolution phase may not be appro-
priately induced and a chronic inflamma-
Figure 1. Inflammatory Pathway Components
The inflammatory pathway consists of inducers, sensors, mediators, and target tissues. Inducers initiate the inflammatory response and are detected by sen-
sors. Sensors, such as Toll-like receptors (TLRs), are expressed on specialized sentinel cells, such as tissue-resident macrophages, dendritic cells, and mast 
cells. They induce the production of mediators, including cytokines, chemokines, bioactive amines, eicosanoids, and products of proteolytic cascades, such as 
bradykinin. These inflammatory mediators act on various target tissues to elicit changes in their functional states that optimize adaptation to the noxious condi-
tion (e.g., infection or tissue injury) associated with the particular inducers that elicited the inflammatory response. The specific components shown represent 
only a small sample of the myriad different sensors, mediators, and target tissues involved in the inflammatory response.
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tory state may ensue. This state can be 
caused by chronic infections, unrepaired 
tissue damage, persistent allergens, undi-
gestable foreign particles, or endogenous 
crystals, such as monosodium urate 
(Kumar et al., 2003; Majno and Joris, 2004). 
The chronic inflammatory response in 
these cases is typically localized to the site 
where the inflammatory inducer is present 
and often results in different types of local 
tissue remodeling. For example, persis-
tent infection can lead to the formation of 
granulomas and the generation of tertiary 
lymphoid organs at the site of infection. 
Similarly, persistent airway inflammation 
induced by allergens can lead to respira-
tory epithelial tissue remodeling resulting 
in asthma.
In addition, a growing number of 
chronic inflammatory conditions have 
been described where the initiating 
trigger is not well defined but does not 
seem to involve infection or tissue dam-
age. These inflammatory conditions 
are of particular interest because they 
accompany many diseases of industri-
alized countries, including obesity and 
type 2 diabetes, atherosclerosis, neu-
rodegenerative diseases, and cancer. 
Interestingly, in these cases of chronic 
inflammation there appear to be vicious 
cycles connecting inflammation and the 
pathological process it accompanies. 
Thus, obesity can lead to inflammation, 
whereas chronic inflammation can pro-
mote obesity-associated diabetes in part 
by inducing insulin resistance (Hotamis-
ligil, 2006). Similar positive feedback 
loops are present in atherosclerosis, 
cancer, and other chronic inflammatory 
diseases. Indeed, this type of recipro-
cal relationship may be responsible, at 
least in part, for the chronic nature of 
these inflammatory conditions and dis-
tinguishes them from the first type of 
chronic inflammation, which is caused 
by persistence of the inflammatory 
inducer. To understand the origin of 
these inflammatory processes we need 
to take a broader view of inflammation 
and its relationship with other systems of 
homeostatic control.
Inflammation: An Adaptive 
 Response to Noxious Conditions
Despite the diversity of inflammatory 
phenomena, fundamentally, inflamma-
tion is an adaptive response to noxious 
conditions. Both beneficial and detri-
mental aspects of inflammation can be 
explained from this perspective. To better 
understand inflammation and inflamma-
tory diseases, we need to consider how 
inflammation is related to other adaptive 
processes that operate at different levels 
in metazoan organisms.
The notion of homeostasis was first 
proposed in 1865 by Claude Bernard, 
who described the constancy of the 
internal environment as a “condition of 
free and independent life.” The idea of 
homeostasis was further developed by 
Metchnikoff. He viewed this process 
as being controlled and maintained by 
phagocytes (Metchnikoff, 1892) and 
proposed the concept of “physiologi-
cal inflammation” to describe the role 
of phagocytes in the active mainte-
nance of “harmony” (i.e., homeostasis). 
These concepts are important because 
inflammation is essentially an adaptive 
response that aims to restore homeosta-
sis. But if this is so, then why is inflam-
mation associated with, and sometimes 
rightfully blamed for, so many diseases, 
particularly the very diseases that are 
caused by a loss of homeostasis? The 
usual answer to this question is that 
inflammation is beneficial in appropriate 
amounts but can easily become detri-
mental when excessive because of its 
tissue-damaging potential. This is cer-
tainly true, but at least two other reasons 
may account for the pathological poten-
tial of inflammatory processes.
The first reason is the consequence 
of a general feature of any adaptive 
response to noxious conditions: it 
always occurs at the expense of normal 
function. For example, cells deal with 
various types of noxious conditions by 
inducing appropriate stress responses 
that ensure adaptation and survival in 
the face of an abnormal cellular environ-
ment. A number of dedicated sensors 
have evolved to detect different stres-
sors and to induce appropriate adaptive 
responses. Thus, heat shock, hypoxia, 
high levels of reactive oxygen species, 
and glucose and amino acid deprivation 
are sensed by HSF-1, HIF-1α, NRF-2, 
AMPK, and ATF4, respectively, result-
ing in alterations in cellular physiology 
that allow for adaptation to abnormal 
conditions. These adaptations occur at 
the expense of normal cellular functions 
and, if persistent, may have detrimental 
consequences. At the level of the organ-
ism, unfavorable environmental condi-
tions, such as cold temperature, nutri-
ent deprivation (caloric restriction), or 
dehydration, affect the switch between 
antagonistic physiological processes 
that promote either reproductive fitness 
or somatic maintenance. This switch is 
controlled by the IGF-1-FOXO pathway, 
with activation of the transcription factor 
FOXO leading to increased stress resis-
tance. In some animals, this transition is 
taken to an extreme by triggering entry 
into a state of suspended animation 
such as the dauer state in nematodes 
or hibernation in certain mammals. 
However, this transition occurs at the 
expense of normal functions, principally 
reproduction. Similarly, the inflammatory 
response (excessive or not) invariably 
occurs at a temporary cost to normal tis-
sue function and therefore is universally 
accompanied by functio laesa.
The second reason for the detrimen-
tal potential of inflammation concerns 
a particular mode of adaptation to cer-
tain types of persistent or extreme con-
ditions. Specifically, one can envision 
two types of adaptation strategies: One 
promotes the restoration of homeosta-
sis by returning the regulated variables 
to homeostatic set points. The second 
strategy is to switch the homeostatic set 
points to different values that are better 
suited to deal with the extreme or per-
sistent abnormal conditions. The inflam-
matory response can engage in both 
modes of adaptation, although the sec-
ond mode has been underappreciated. 
Nevertheless, changes in homeostatic 
set points may be particularly important 
in chronic inflammatory diseases, such 
as obesity and type 2 diabetes. Indeed, 
inflammation can induce a switch in 
metabolic homeostatic set points, for 
example, through its effect on insulin 
sensitivity, which may be intended for 
the reallocation of nutrients under condi-
tions of stress or infection. This intended 
and beneficial mechanism can, however, 
become detrimental not because inflam-
mation is excessive, but because the 
changes in homeostatic set points can 
become maladaptive in, and perpetu-
ated by, the “unnatural” environment of 
industrialized countries. In other words, 
the intended, beneficial role of this mode 
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of adaptation can become 
detrimental because of the 
mismatch between the cur-
rent environment and the 
evolutionary pressures of the 
past (Gluckman and Hanson, 
2004).
Inflammation: A Tissue 
Stress Response
The analogy between inflam-
mation and stress responses 
is illustrative for an additional 
reason: local inflammation 
can be thought of as a tis-
sue stress response, whereas 
systemic inflammation is 
clearly a specialized type of 
stress response that occurs at 
the level of the whole organ-
ism. In fact, in some cases it 
is not obvious where to draw 
the line between the classical 
cellular stress response and 
inflammation. The main dis-
tinction may be that cellular 
stress responses are largely 
cell-autonomous adaptations, 
whereas inflammation typi-
cally operates at the tissue or 
organismal level. However, 
the origin of the inflammatory 
response may become clearer 
if we consider that even 
classical stress responses 
have non-cell-autonomous 
components. For example, 
hypoxia is sensed by HIF-1α 
and induces cellular adapta-
tion to a shortage of oxygen, 
but it also results in produc-
tion of vascular endothelial 
growth factor, which induces 
tissue adaptation through 
angiogenesis. Viral infections 
induce cell-autonomous anti-
viral responses but also lead 
to production of IFN-β, which 
induces tissue level adapta-
tion to the virus by inducing an 
antiviral state in the surround-
ing cells. Indeed most, if not 
all, cellular stress responses, 
in addition to cell-autonomous 
adaptive changes, produce secreted fac-
tors that affect other cells in the tissue, 
including resident macrophages. In fact, 
tissue-resident macrophages may be spe-
cialized sentinel cells that sense not only 
injury and infection but also other types of 
noxious conditions such as hypoxia and 
metabolic stress. Indeed, macrophages 
have many trophic functions 
that are essential for tissue 
maintenance and homeostasis 
(Pollard, 2009), and presum-
ably for stress adaptation as 
well. Depending on the nature 
and extent of the problem, the 
tissue-resident macrophages 
may recruit additional cells 
(e.g., different types of mono-
cytes) to the affected tissue 
even when the problem is 
not associated with infection 
or injury. Thus, macrophages 
infiltrate the adipose tissue 
of obese animals, a phenom-
enon with well-appreciated 
pathological consequences 
(insulin resistance) but an 
unknown physiological pur-
pose (Schenk et al., 2008). 
The tissue stress response 
orchestrated by macrophages 
and mast cells is intermediate 
between the cell-autonomous 
stress response and the bona 
fide inflammatory response 
and can be referred to as 
“parainflammation” (Medzhi-
tov, 2008) (Figure 2).
Regulation of the 
 Inflammatory Response
The inflammatory response 
can be controlled at multiple 
levels (Nathan, 2002), but the 
regulatory principles are still 
incompletely understood, in 
part due to the complexity of 
the inflammatory response 
and the multitude of compo-
nents involved. One way to 
deconvolute this complex-
ity is to distinguish among 
different checkpoints in the 
inflammatory response and 
to consider the different 
modes of action of regula-
tory signals.
In principle, the inflam-
matory response can be 
controlled at four levels, cor-
responding to the four com-
ponents of the inflammatory 
pathway: inducers, sensors, media-
tors, and target tissues. One key con-
trol point, which is regulated by major 
anti-inflammatory signals (e.g., IL-10, 
Figure 2. Inflammation and the Stress Response
Inflammation is an adaptive response to noxious conditions. 
(A) Under normal conditions, tissue-resident macrophages maintain tissue 
homeostasis by removing dead cells and other debris and by producing 
growth factors. 
(B) Under noxious conditions, the cellular stress response is activated and re-
sults in a cell-autonomous adaptation. But it may also involve communication 
between stressed cells and other cells in the tissue environment, including 
resident macrophages. 
(C) If the nature or the extent of stress is such that it affects not only individual 
cells but the entire tissue (e.g., hypoxia or hyperthermia), then a tissue-level 
stress response, or parainflammation, is elicited by the resident macrophages 
(and in some tissues by mast cells). Depending on the degree of the nox-
ious condition, this response can involve the recruitment of different types 
of inflammatory monocytes from the circulation. Parainflammation may also 
involve low-level release of plasma components into the affected tissue. 
(D) Finally, if the condition is severe enough (e.g., infection or injury), an acute 
inflammatory response ensues. This is characterized by the recruitment of 
neutrophils and specialized subsets of monocytes from the circulation that 
help to protect the host from infection and promote tissue repair and resto-
ration of homeostasis. (Only a few examples of inflammatory mediators are 
shown.)
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TGF-β, glucocorticoids), is production 
of inflammatory mediators. However, 
anti-inflammatory signals could also 
act on the target tissue itself. First, the 
responsiveness of the target tissue to 
inflammatory mediators can be regu-
lated at the level of receptors and signal-
ing pathways activated by the mediators. 
This mode of regulation affords an extra 
level of specificity by controlling which 
tissues respond, as well as the extent 
and duration of the response, to a given 
mediator. Notably, many inflammatory 
mediators, for example PGE2, can signal 
through multiple receptor subtypes that 
may have opposite effects on target tis-
sues. In other cases, the action of inflam-
matory mediators can be dampened by 
decoy receptors, again providing spe-
cific control of target tissues. Switch-
ing the expression of different types of 
receptors may contribute to this mode 
of regulation. Second, anti-inflammatory 
signals can act by reversing the effects 
of the mediators on the target tissue. For 
example, noradrenaline can reverse the 
effects of histamine and bradykinin on 
bronchiole smooth muscle by inducing 
bronchodilation. Vasoconstriction and 
vasodilation can also be controlled by 
pro- and anti-inflammatory signals with-
out affecting the production of inflam-
matory mediators. The advantage of this 
type of control mechanism is that it can 
selectively regulate responsiveness of 
different target tissues without affect-
ing the overall strength or duration of the 
inflammatory response.
Regulatory mechanisms are often 
specific for a particular component of 
the inflammatory response. Thus, rather 
than shutting down the response com-
pletely, many anti-inflammatory signals 
selectively inhibit certain aspects of the 
response. Examples include the effects 
of IL-10 and glucocorticoids on TLR-
induced inflammatory responses in 
macrophages. These anti-inflammatory 
signals inhibit expression of only 10% 
to 15% of TLR-inducible target genes. 
The same appears to be true for many 
other anti-inflammatory signals. The 
reason for this selectivity of regulation 
is that the response induced by inflam-
matory sensors, such as TLRs, typically 
has multiple functional components. 
Thus, in addition to inflammatory medi-
ators, TLRs induce expression of anti-
microbial, tissue repair, and metabolic 
genes. These components may need 
to be regulated independently of each 
other, which presumably explains why 
major anti-inflammatory signals act in a 
component-specific manner. Mechanis-
tically, this type of control is commonly 
performed at the level of gene tran-
scription. Elucidating the physiological 
rationale underpinning this specificity of 
regulation is an important challenge for 
future studies.
Another important aspect of the con-
trol of the inflammatory response is the 
way in which anti-inflammatory signals 
are produced. For example, IL-10 is 
produced as a result of an inflamma-
tory response and is a component of an 
activity-dependent negative-feedback 
loop. IL-10 typically inhibits the response 
that initiated its own production and 
acts on cells that produce inflammatory 
mediators, such as macrophages or T 
cells. Although glucocorticoids can be 
induced by inflammation (Besedovsky 
and del Rey, 2000), they also can be pro-
duced in response to signals unrelated 
to the inflammatory response (psycho-
logical stress, the circadian clock) and 
can act on almost any cell, including 
cells that are targets of the inflammatory 
response. Thus, IL-10 and glucocorti-
coids (and several nuclear receptors) act 
in a manner that is intrinsic or extrinsic to 
the inflammatory pathway, respectively. 
Not surprisingly, IL-10 and glucocorti-
coids have nonredundant roles in the 
control of inflammation, and it would be 
useful to compare their distinct regula-
tory functions under different inflamma-
tory conditions.
Challenges and Perspectives
Inflammation comprises a diverse range 
of processes that affect every aspect of 
normal physiology and pathology. The 
field has become too large and amor-
phous to fit into a single discipline, let 
alone to be covered in a brief overview. 
Although individual branches of inflam-
mation research have proceeded at dif-
ferent paces and in ever more divergent 
directions, there are still some common 
principles that remain to be elucidated. 
For example, there is no satisfactory the-
ory that explains the chronic inflamma-
tory states associated with diseases of 
homeostasis. The inflammatory inducers 
responsible for many chronic inflam-
matory states are not clearly defined, 
although recent advances have impli-
cated certain stress response compo-
nents (Hotamisligil, 2006). Connections 
between cellular stress and inflamma-
tion warrant further study. In particu-
lar, little is known about the non-cell-
autonomous aspects of cellular stress 
responses. Analyses of cell commu-
nication during stress responses are 
likely to reveal new principles of tissue 
homeostasis and adaptation to noxious 
conditions. Although many molecules 
have been implicated as inflammatory 
inducers during tissue injury, their rela-
tive contributions are poorly defined and 
which of them, if any, are essential for the 
induction of the inflammatory response 
is unclear.
The relationship between inflamma-
tory and adaptive immune responses is 
also incompletely understood. Although 
inflammation is likely to be required 
for the induction of adaptive immune 
responses, it is clearly not sufficient. It 
is important to note that inflammatory 
responses to infection and to sterile tis-
sue injury have different purposes: the 
former aims to protect the host from 
infection and can be coupled with the 
induction of adaptive immunity, whereas 
the latter primarily serves to promote 
tissue repair. A detailed analysis of the 
inflammatory mediators induced under 
the two conditions should help to eluci-
date the distinct features of inflammation 
induced by infection and injury.
An excessive inflammatory response 
is detrimental due to its negative effect 
on tissue function and, when extreme, 
results in overt tissue damage. Apart 
from the acute phase of the inflamma-
tory response, however, other stages 
of the inflammatory process can also 
become dysregulated. A dysregulated 
tissue repair response with accompa-
nying tissue remodeling, fibrosis, and 
persistent tissue metaplasia can lead to 
the decline or complete loss of normal 
tissue function as happens, for example, 
in asthma. One can imagine that dys-
regulation of the resolution of inflamma-
tion may similarly contribute to tissue 
pathology. It would also be interesting 
to investigate whether pathogens that 
establish chronic infections, such as the 
bacterium Mycobacterium tuberculosis, 
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may trigger a dysregulated resolution 
response as part of their immune eva-
sion strategy.
Inflammatory tissue damage and 
immunopathology incur high fitness 
costs, and the fact that they have been 
maintained during evolution may reflect 
a trade-off with the beneficial, often 
life-saving, functions of the inflamma-
tory response. The question remains, 
however, of whether specialized mecha-
nisms exist that have evolved to minimize 
inflammatory tissue damage. If so, these 
mechanisms may operate without affect-
ing the protective aspects of inflamma-
tion, for example, by controlling target 
tissue responsiveness to inflammatory 
mediators, or by increasing tissue resis-
tance to inflammatory damage through 
induction of cytoprotective mechanisms 
(Seixas et al., 2009).
One of the most daunting aspects of 
studying inflammation is the diversity and 
complexity of the inflammatory media-
tors and their effects on target tissues. 
Although mechanistic aspects of their 
effects are relatively well understood, 
their coordinate functions in the context 
of intact tissues and their multiple modes 
of regulation are poorly defined.
Inflammation research has come a 
long way from the first description of its 
cardinal signs by Celsus almost two mil-
lennia ago. Although much time has been 
spent studying inflammation in patho-
logical contexts, increasingly, inflamma-
tion occupies a central position in many 
branches of biology. This is reflected by 
the broad range of subjects discussed in 
the Reviews and Essays in this Cell spe-
cial issue on inflammation.
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